Rishabh Lifescience Profile
Key Indicators
- Authorised Capital ₹ 3.01 Cr
- Paid Up Capital ₹ 3.00 Cr
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 30.00 Cr
- Revenue Growth -18.77%
- Profit Growth -51.11%
- Ebitda -33.50%
- Net Worth 23.84%
- Total Assets -2.81%
About Rishabh Lifescience
Rishabh Lifescience Private Limited (RLPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 December 2019 (Five years and two months 4 days old ). Its registered office is in Kadi, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.01 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹30.00 Cr.
Pathik Shah and Krutarth Shah serve as directors at the Company.
Company Details
-
Location
Kadi, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24299GJ2019PTC111251
-
Company No.
111251
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Dec 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Rishabh Lifescience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krutarth Shah
|
Managing Director | 06-Dec-2019 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Pathik Shah
|
Director | 06-Dec-2019 | Current |
Financial Performance of Rishabh Lifescience.
Rishabh Lifescience Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.77% decrease. The company also saw a substantial fall in profitability, with a 51.11% decrease in profit. The company's net worth Soared by an impressive increase of 23.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rishabh Lifescience?
In 2023, Rishabh Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vardhaman Stampings Private LimitedPathik Shah and Krutarth Shah are mutual person
-
Spi Industries Private LimitedPathik Shah and Krutarth Shah are mutual person
-
Navkar Transcore Private LimitedPathik Shah and Krutarth Shah are mutual person
-
Rishabh Technologies Private LimitedPathik Shah and Krutarth Shah are mutual person
Charges (Loans)
₹30.00 Cr
₹0
Charges Breakdown by Lending Institutions
- The Kalupur Commercial Co-Operative Bank Limited : 30.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Aug 2020 | The Kalupur Commercial Co-Operative Bank Limited | ₹15.00 Cr | Open |
| 28 Aug 2020 | The Kalupur Commercial Co-Operative Bank Limited | ₹15.00 Cr | Open |
How Many Employees Work at Rishabh Lifescience?
Unlock and access historical data on people associated with Rishabh Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rishabh Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rishabh Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.